TARO - Taro Pharmaceutical Industries Ltd.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/A2.17N/AN/A
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
No. of Analysts1121
Avg. Estimate174.7M189.92M699.95M822.53M
Low Estimate174.7M189.92M686.65M822.53M
High Estimate174.7M189.92M713.24M822.53M
Year Ago Sales155.46M175.22M661.91M699.95M
Sales Growth (year/est)12.40%8.40%5.70%17.50%
Earnings HistoryInvalid Date3/30/20186/29/20189/29/2018
EPS Est.N/A1.512.331.96
EPS ActualN/A2.171.711.52
DifferenceN/A0.66-0.62-0.44
Surprise %N/A43.70%-26.60%-22.40%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
Current Estimate0000
7 Days Ago2.152.437.8211.16
30 Days Ago2.152.437.8211.16
60 Days Ago2.152.437.8211.16
90 Days Ago2.152.437.8211.16
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTAROIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.48
Next Qtr.N/AN/AN/A0.40
Current YearN/AN/AN/A0.21
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)-12.95%N/AN/A0.11
Past 5 Years (per annum)-8.60%N/AN/AN/A